US FDA orders new vision loss warnings on GLP-1 drugs

In 50 words

The US Food and Drug Administration (FDA) is requiring makers of GLP-1 weight-loss medicines to update their safety labels. The labels must warn of a possible higher risk of a rare but serious eye condition that can cause permanent vision loss, Euronews reported.